Abraham Ceesay insider trades

Open-market stock purchases and sales by Abraham Ceesay, Chief Executive Officer at Rapport Therapeutics, Inc, from SEC Form 4 filings since Jan 17, 2018.

Recent trades

DateStockTradeValue
Oct 7, 2026RAPP Rapport Therapeutics, IncSold$35.2K
Oct 6, 2026RAPP Rapport Therapeutics, IncSold$108K
Sep 23, 2026RAPP Rapport Therapeutics, IncSold$76.2K
Sep 23, 2026RAPP Rapport Therapeutics, IncSold$8.6K
Sep 23, 2026RAPP Rapport Therapeutics, IncSold$1.8K
Sep 8, 2026RAPP Rapport Therapeutics, IncSold$325K
Sep 8, 2026RAPP Rapport Therapeutics, IncSold$49.2K
Aug 25, 2026RAPP Rapport Therapeutics, IncSold$938K
Aug 11, 2026RAPP Rapport Therapeutics, IncSold$172K
Aug 11, 2026RAPP Rapport Therapeutics, IncSold$937K
Aug 11, 2026RAPP Rapport Therapeutics, IncSold$282K
Aug 10, 2026RAPP Rapport Therapeutics, IncSold$651K
Aug 10, 2026RAPP Rapport Therapeutics, IncSold$391K
Jul 27, 2026RAPP Rapport Therapeutics, IncSold$92.8K
Jul 27, 2026RAPP Rapport Therapeutics, IncSold$299
Jul 14, 2026RAPP Rapport Therapeutics, IncSold$218K
Jul 14, 2026RAPP Rapport Therapeutics, IncSold$111K
Jun 29, 2026RAPP Rapport Therapeutics, IncSold$292K
Jun 29, 2026RAPP Rapport Therapeutics, IncSold$35.3K
May 8, 2026CRL Charles River Laboratories International, IncBought (not open market)$255K
Feb 18, 2026RAPP Rapport Therapeutics, IncSold$103K
Feb 18, 2026RAPP Rapport Therapeutics, IncSold$68K
Feb 18, 2026RAPP Rapport Therapeutics, IncSold$86.6K
Feb 18, 2026RAPP Rapport Therapeutics, IncSold$62.6K
Feb 2, 2026RAPP Rapport Therapeutics, IncBought (not open market)—

Companies traded

  • RAPP Rapport Therapeutics, Inc: 43 sales, last Oct 7, 2026
  • CRL Charles River Laboratories International, Inc: other filings, last May 8, 2026
  • PCRX Pacira BioSciences, Inc: 1 sale, last Sep 4, 2025
  • CERE Cerevel Therapeutics Holdings, Inc: 6 sales, last Feb 6, 2023
  • SCPH scPharmaceuticals Inc: other filings, last Jan 17, 2018

Get free alerts when Abraham Ceesay files a new trade →